The effectiveness of biomarkers has made them essential to medicine, with successful products on the market and many products in development. This Kalorama Information report focuses on both the clinical biomarkers and research biomarkers in medicine.
Biomarkers are physiologic, genetic or biochemical parameters that provide insight into understanding disease processes and ways that medicines can work to counteract the disease. With them, diseases are detected earlier, more effective treatments can be delivered, drug reactions reduced. An example is creatine kinase, or CK-MB, a marker that facilitates high-energy phosphates in the body’s tissues, and can suggest a cardiovascular event when levels are high. Other markers can identify the seriousness of tumors or signal immune system problems.
These biomarkers are valuable in assessing risk, detecting current disorders or diseases, treatment assessments, drug matching, etc. In research, biomarkers are useful for drug development and determining new markers for drug targeting.
The report will provide a market analysis for five broad areas of medical biomarkers:
The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including microbiologists, pathologists, hospital authorities, reimbursement specialists, research scientists, business development managers and marketing managers.
All market data are based on factory sales to the end user and not retail pricing or reimbursement payments. Market data pertains to the world market at the manufacturers’ level. The base year for data was 2013. Historical data was provided for the years 2008 through 2012, with forecast data provided for 2014 through 2018. Compound annual growth rates (CAGRs) are provided for the 2008-2013 and 2013-2018 periods for each segment covered.
Basic competitor summaries are included in each segment. The forecasted market analysis for 2014-2018 was largely based on demographic trends, new developments, biomarker development, company performance trends, merger and acquisitions, and global expansion.
Company profiles in this report include:
Related Reports:Cardiac Markers
Jun 16, 2016 - KLI15030206 - $1,995.00
The World Market for Companion Diagnostic Tests
Jun 7, 2016 - KLI15021881 - $4,200.00
The World Market for Infusion Pumps (Large Volume Pumps, Ambulatory Pumps, Insulin Pumps, Enteral Feeding Pumps, Others)
Jun 6, 2016 - KLI15021669 - $4,200.00
Surgical Procedure Volumes: Global Analysis (United States, China, Japan, Brazil, United Kingdom, Germany, France, Italy, Mexico, Australia, Canada)
May 20, 2016 - KLI15006734 - $4,200.00
The Global Market for Medical Devices, 7th Edition
May 13, 2016 - KLI15002686 - $1,500.00
MicroRNA Tools and Services Market
May 3, 2016 - KLI5985878 - $4,200.00
Vaccines 2016: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus , HIB, Others)
Mar 25, 2016 - KLI5948213 - $4,200.00
Biomarker-Based Tests: Faster Revenue Growth
Feb 26, 2016 - KLI5912540 - $0.00
The World Market for Laboratory Information Systems
Feb 11, 2016 - KLI5881925 - $4,200.00
Growth Potential of Specific Biomarker-Based Tests: White Paper
Feb 9, 2016 - KLI5878138 - $0.00
Questions?Contact a research specialist >
Live Chat Software
Most Popular ResearchNext Generation Sequencing (NGS) Markets 2015 (Systems, Consumables, Services, Acquisitions, Agreements, Competitive Analysis, Platforms, Applications, Brand Ownership and Other Trends) Proteomics Markets for Clinical IVD Applications and Research Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) Growth Potential of Specific Biomarker-Based Tests: White Paper Physician Office Laboratory (POL) Markets, 3rd Edition (Markets for Office-Based Chemistry, Glucose, Coagulation PT, Autoimmune, HIV, Hep, Cardiac Markers, PSA, Flu, HbA1c, Hematology, FOB and Other Tests) qPCR and dPCR Markets (Instruments, Reagents, Software/Services, Clinical and Research Markets) Library Preparation and Target Enrichment for Next Generation Sequencing Product Markets